![](https://i2.wp.com/hrnxt.com/wp-content/uploads/2021/04/Hemmo_site.jpg?resize=200%2C112&ssl=1)
Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced that PPL has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals Pvt Ltd. (Hemmo) for an upfront consideration of INR 775 crores and earn-outs linked to achievement of milestones. As PPS continues to expand and grow…